Aquestive Therapeutics Correlations
AQST Stock | USD 3.10 0.01 0.32% |
The current 90-days correlation between Aquestive Therapeutics and Ironwood Pharmaceuticals is 0.15 (i.e., Average diversification). The correlation of Aquestive Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Aquestive Therapeutics Correlation With Market
Good diversification
The correlation between Aquestive Therapeutics and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Aquestive |
Moving together with Aquestive Stock
0.64 | EQ | Equillium | PairCorr |
0.68 | VALN | Valneva SE ADR | PairCorr |
0.85 | DNLI | Denali Therapeutics | PairCorr |
0.68 | DNTH | Dianthus Therapeutics | PairCorr |
0.83 | DOMH | Dominari Holdings | PairCorr |
0.8 | DRRX | Durect | PairCorr |
0.9 | DTIL | Precision BioSciences | PairCorr |
0.89 | VIGL | Vigil Neuroscience | PairCorr |
0.86 | VINC | Vincerx Pharma | PairCorr |
0.93 | VKTX | Viking Therapeutics | PairCorr |
0.8 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.82 | VRDN | Viridian Therapeutics Buyout Trend | PairCorr |
0.85 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.79 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against Aquestive Stock
0.89 | DRTS | Alpha Tau Medical | PairCorr |
0.8 | CDIOW | Cardio Diagnostics | PairCorr |
0.76 | SRZNW | Surrozen Warrant | PairCorr |
0.74 | DMAC | DiaMedica Therapeutics | PairCorr |
0.72 | DYAI | Dyadic International | PairCorr |
0.69 | VCYT | Veracyte Potential Growth | PairCorr |
0.67 | VCEL | Vericel Corp Ord | PairCorr |
0.61 | SABSW | SAB Biotherapeutics | PairCorr |
0.5 | DVAX | Dynavax Technologies | PairCorr |
0.39 | A | Agilent Technologies | PairCorr |
0.37 | KTTAW | Pasithea Therapeutics | PairCorr |
0.86 | VRNA | Verona Pharma PLC | PairCorr |
0.81 | ENTX | Entera Bio | PairCorr |
0.76 | ELTX | Elicio Therapeutics | PairCorr |
0.63 | VSTM | Verastem | PairCorr |
0.53 | ELEV | Elevation Oncology | PairCorr |
0.31 | VYNE | Vyne Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aquestive Stock performing well and Aquestive Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aquestive Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EVOK | 3.81 | (0.05) | 0.00 | (0.05) | 0.00 | 7.55 | 48.38 | |||
ADMP | 4.75 | (1.79) | 0.00 | (2.09) | 0.00 | 8.72 | 40.76 | |||
GHSI | 5.47 | 0.67 | 0.07 | 8.09 | 8.11 | 18.66 | 101.05 | |||
ACRX | 4.72 | 0.52 | 0.11 | 0.33 | 4.26 | 13.85 | 29.52 | |||
DVAX | 1.38 | 0.27 | 0.12 | 1.31 | 1.73 | 3.69 | 17.05 | |||
AMPH | 1.67 | (0.47) | 0.00 | (1.51) | 0.00 | 3.57 | 17.26 | |||
LNTH | 2.08 | (0.25) | 0.00 | (0.33) | 0.00 | 4.00 | 27.61 | |||
ANIP | 1.55 | 0.00 | (0.01) | 0.02 | 1.97 | 2.64 | 9.65 | |||
IRWD | 3.85 | (0.14) | 0.00 | (0.09) | 0.00 | 12.14 | 29.57 | |||
ALKS | 1.41 | 0.02 | 0.01 | 0.06 | 1.64 | 3.90 | 9.74 |
Aquestive Therapeutics Corporate Management
Carl MD | Chief Officer | Profile | |
Alexander Schobel | Chief Officer | Profile | |
BSBA Esq | Sr Counsel | Profile | |
Kenneth MD | Chief Officer | Profile | |
Kenneth Marshall | Chief Officer | Profile | |
Ernest Toth | Chief Officer | Profile | |
Stephen Wargacki | Senior Development | Profile |